BROOKE E. DANIEL MD NPI 1326096231

NPI Information

  • NPI: 1326096231
  • Provider Name: BROOKE E. DANIEL, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 605 GLENWOOD DR
    SUITE 200
    CHATTANOOGA, TN
    ZIP 37404
  • Phone: (423) 698-1844

Map and Directions

Get Directions

NPI Details

Brooke E. Daniel, MD is a hematology and oncology internal medicine in Chattanooga, TN with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Brooke E. Daniel, MD NPI is 1326096231. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:1998

The provider's business location address is:

605 GLENWOOD DR
SUITE 200
CHATTANOOGA, TN
ZIP 37404-108
Phone: (423) 698-1844
Fax: (423) 624-2226

The NPI 1326096231 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Blood creatinine level (HCPCS:82565)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Folic acid level, serum (HCPCS:82746)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Vitamin d-3 level (HCPCS:82306)

The enumeration date for this NPI number is 5/4/2006 and was last updated on 7/9/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology056540GEORGIANo
2207RH0003XInternal MedicineHematology & OncologyMD39893TENNESSEEYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1H57893MEDICARE UPINTENNESSEE
23332038MEDICARE ID-TYPE UNSPECIFIEDTENNESSEE
3332038MEDICAIDTENNESSEE
490BDBLVMEDICARE ID-TYPE UNSPECIFIEDGEORGIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.